Enliven Therapeutics
Stock Forecast, Prediction & Price Target
Enliven Therapeutics (ELVN) stock Price Target by analysts
$39.5
Potential upside: 99.89%
Enliven Therapeutics price prediction
What is Enliven Therapeutics stock analysts` prediction?
Enliven Therapeutics stock forecast: Based on 2 Wall Street analysts` predicted price targets for Enliven Therapeutics in the last 3 months, the avarage price target is $39.5, with a high forecast of $NaN. The average price target represents a 99.89% change from the last price of $19.76.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Enliven Therapeutics stock Price Target by analysts
Full breakdown of analysts given Enliven Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Colleen Kusy Robert W. Baird | 0% 0/2 | 10 months ago | $40 102.42% upside | $24.05 | StreetInsider | Previous targets (1) |
Salim Syed Mizuho Securities | 0% 0/2 | 12 months ago | $39 97.36% upside | $23.8 | StreetInsider | Previous targets (1) |
Colleen Kusy Robert W. Baird | 0% 0/2 | about 1 year ago | $32 61.94% upside | $22.58 | StreetInsider | Previous targets (1) |
Salim Syed Mizuho Securities | 0% 0/2 | over 1 year ago | $34 72.06% upside | $18.3 | StreetInsider | Previous targets (1) |
Enliven Therapeutics Financial Estimates
Enliven Therapeutics Revenue Estimates
Enliven Therapeutics EBITDA Estimates
Enliven Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $16.67K Low: $16.67K High: $16.67K avg. 0% | Avg: $16.67K Low: $16.67K High: $16.67K avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $10M Low: $10M High: $10M avg. 0% |
Net Income
% change YoY
| $-24.71M N/A | $-37.75M -52.72% | $-71.58M -89.62% | Avg: $-130.46M Low: $-120.85M High: $-85.31M avg. -82.25% | Avg: $-168.47M Low: $-142.89M High: $-102.01M avg. -29.13% | Avg: $-138.09M Low: $-138.09M High: $-138.09M avg. 18.03% | Avg: $-126.18M Low: $-126.18M High: $-126.18M avg. 8.62% |
EBITDA
% change YoY
| $-24.64M N/A | $-38.57M -56.51% | $-81.93M -112.39% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$10.72 N/A | -$12.08 -12.68% | -$2.01 83.36% | Avg: -$2.86 Low: -$3.4 High: -$2.4 avg. -42.18% | Avg: -$3.35 Low: -$4.02 High: -$2.87 avg. -17.12% | Avg: -$3.89 Low: -$3.89 High: -$3.89 avg. -16.05% | Avg: -$3.55 Low: -$3.55 High: -$3.55 avg. 8.62% |
Operating Expenses
% change YoY
| $24.76M N/A | $38.79M 56.65% | $83.52M 115.33% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Enliven Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -21.18% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -120.85M, average is -130.46M and high is -85.31M.
What is Enliven Therapeutics stock revenue growth forecast?
We have gathered data from 2 analysts. Their low revenue estimate is $16.67K, average is $16.67K and high is $16.67K.
What is Enliven Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -16.68% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$3.4, average is -$2.86 and high is $-2.4.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Enliven Therapeutics stock. The most successful analyst is Colleen Kusy.